Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.534 USD | +0.77% | -15.07% | +4.31% |
May. 09 | Earnings Flash (ATRA) ATARA BIOTHERAPEUTICS Reports Q1 Revenue $27.4M | MT |
Apr. 01 | Stifel Adjusts Atara Biotherapeutics Price Target to $2.30 From $4.80, Maintains Hold Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.31% | 63.81M | |
+4.57% | 109B | |
+11.26% | 105B | |
+0.70% | 22.25B | |
-11.70% | 22.09B | |
-7.73% | 18.68B | |
-38.36% | 17.58B | |
-10.50% | 16.85B | |
+4.62% | 13.76B | |
+37.25% | 12.46B |
- Stock Market
- Equities
- ATRA Stock
- News Atara Biotherapeutics, Inc.
- Goldman Sachs Adjusts Atara Biotherapeutics' Price Target to $3 From $4, Keeps Sell Rating